Trypanosoma cruzi amastigotes present receptors for human fibronectin as indicated by the saturable binding of [125I]fibronectin to this form of the parasite. Scatchard analysis indicates that the number of fibronectin receptors per amastigote was 1.3 x 103 with a Kd of approximately 2.3 nM. Addition of physiological concentrations of fibronectin to amastigote-macrophage cocultures significantly increased the binding of amastigotes to murine macrophages. This increase was evidenced in both the number of amastigotes bound to macrophages and the percentage of macrophages containing bound amastigotes. The uptake of amastigotes by either murine macrophages or human blood monocytes was also increased in the presence of exogenous fibronectin. The increase induced by fibronectin was blocked when amastigotes were pretreated with the RGDS tetrapeptide of the fibronectin cell attachment site. Furthermore, the ability of fibronectin to enhance amastigote binding to and uptake by macrophages was inhibited by the F(ab')2 fragment of anti-fibronectin immunoglobulin G (IgG) but not by an irrelevant anti-human IgG F(ab')2 fragment. Pretreatment of either amastigotes or macrophages with fibronectin also resulted in a significant increase in amastigote binding to and uptake by macrophages. These results suggest that fibronectin may play a role in facilitating the attachment and ingestion of T. cruzi amastigotes by macrophages and monocytes in chagasic tissue lesions.
Trypanosoma cruzi, a protozoan affecting millions of people in South and Central America, requires an intracellular location to multiply and amplify the disease in mammalian hosts (2) . Macrophages and monocytes interact with and ingest amastigotes, the multiplicative form of the parasite, at inflammatory sites (7) . The processes by which inflammatory cells kill amastigote forms of T. cruzi have been reported (20) (21) (22) (23) , but the mechanisms by which this form of the parasite binds to and is ingested by macrophages and monocytes are poorly understood. Macrophage-monocyte interactions with amastigotes are important because these phagocytic cells play a role in the immunomodulation of the host response to T. cruzi (S. A. Howard and F. Villalta, manuscript in preparation).
Fibronectin (Fn) is a glycoprotein produced by both macrophages and monocytes (1, 6) and is secreted in increased amounts during inflammatory processes (12, 14) . These cells are found to be present in inflammatory sites containing T. cruzi amastigotes (7) and also to participate in the destruction of this form of the parasite (20) (21) (22) (23) . In this work, we investigate the effect of this glycoprotein on the binding and uptake of amastigotes by murine macrophages and human monocytes.
MATERIALS AND METHODS Animals. Crl:CD-1(ICR)BR Swiss mice aged 7 weeks from Charles River Breeding Laboratories, Inc. (Raleigh, N.C.) were used as a source of mouse peritoneal macrophages.
Parasites. The Tulahuen strain of T. cruzi was used in this work. Blood trypomastigotes isolated from infected mice by chromatography on a diethylaminoethyl-cellulose column (9) were used to infect Vero cell cultures (19) . Amastigotes released from these infected cells were isolated on a metrizamide gradient (19) and grown in ML-15HA medium as described previously (19) . Amastigotes were also isolated from the spleens of infected mice (9) . No enzymes were used * Corresponding author. in this procedure. The latter amastigotes were purified in a linear sucrose gradient (9) followed by a metrizamide gradient (19) . Amastigotes grown in ML-15HA or isolated from the spleens of infected mice were washed by centrifugation with Dulbecco modified minimal essential medium supplemented with 100 U of penicillin and 100 ,ug of streptomycin per ml (DMEM; GIBCO Laboratories, Grand Island, N.Y.). To study the interaction between amastigotes and macrophages or monocytes, suspensions of parasites were adjusted to 1 x 107 organisms per ml in DMEM supplemented with 1% bovine serum albumin (DMEM-BSA; Sigma Chemical Co., St. Louis, Mo. Measurement of amastigote uptake by mouse peritoneal macrophages or human blood monocytes. The procedure to measure amastigote uptake by human blood monocytes and mouse peritoneal macrophages has been described (21, 24) . Briefly, mouse peritoneal macrophages or human blood monocyte monolayers were washed with DMEM. These cultures then received 100 RI of amastigote suspension in DMEM-BSA and 100 ,ul of DMEM-BSA or DMEM-BSA supplemented with selected concentrations of Fn, goat F(ab')2 fragment of anti-human Fn immunoglobulin G (IgG) (Cooper Biomedical, Inc., Malvern, Pa.), goat F(ab')2 fragment of anti-human IgG (Sigma, St. Louis, Mo.), or a combination of these agents. The cocultures were incubated in 5% CO2 at 37°C for 2 h. Under these conditions, the majority of cell-bound amastigotes were ingested by macrophages (21, 24, 25) or monocytes (21) , as further confirmed by electron microscopy studies (results not shown). The unbound parasites were removed by washing each culture chamber with DMEM. The cocultures were fixed, stained, and counted as described above.
Pretreatment of amastigotes and macrophages with Fn or RGDS. Amastigotes or macrophages were washed with DMEM and preincubated at 4°C for 1 h with DMEM-BSA or DMEM-BSA containing Fn (200 ,ug/ml). In some experiments, amastigotes were also pretreated with the RGDS tetrapeptide (2 mg/ml in DMEM-BSA) of the Fn cell attachment site (CalBiochem 
RESULTS
Binding of radiolabeled Fn to T. cruzi amastigotes. The binding of radiolabeled human Fn to T. cruzi amastigotes was specific and saturable, indicating the presence of Fn receptors on this form of the parasite (Fig. 1) . As indicated in the insert of Fig. 1 (Table 3 ). In addition, the enhancing effect of Fn on amastigote-macrophage interactions was also observed at concentrations up to 500 ,ug/ml. The ability of Fn to increase parasite uptake by macrophages varied occasionally between different experiments of similar protocols. However, the increase in amastigote uptake by macrophages was always observed in the presence of Fn. Pretreatment of either macrophages or amastigotes with Fn also caused a significant increase in the uptake of parasites by macrophages (Table 4) . Furthermore, the enhancing effect of Fn on amastigote uptake by macrophages could be inhibited by an antihuman Fn F(ab')2 fragment but not by an anti-human IgG F(ab')2 fragment ( Table 5 ). The presence of either F(ab')2 fragment in the absence of Fn did not significantly alter parasite-host cell association with respect to control values ( Table 5 ). Pretreatment of amastigotes with the tetrapeptide RGDS (that contains the Fn cell attachment site) (15, 16, 27) inhibited the enhancing effect of Fn on parasite uptake by macrophages (Table 6 ).
In the presence of Fn, human blood monocytes showed a significant increase in their ability to take up amastigotes ( Table 7 ). The ability of Fn to enhance amastigote uptake by monocytes was inhibited when amastigotes were pretreated with RGDS. In the absence of Fn, RGDS had no effect on the ability of monocytes to take up amastigotes with respect to control values ( Table 7) .
The ability of macrophages to take up amastigotes isolated from the spleens of infected mice was significantly enhanced by Fn. In a representative experiment, addition of Fn caused a statistically significant increase in both the percentage of macrophages containing amastigotes (24.8 + 0.5) and the number of amastigotes per 100 macrophages (27.6 + 0.5) when these values were compared with control values (16.8 ± 1.6 and 18.4 ± 1.1, respectively). The enhancing effect of Fn in these experiments was similar to that observed in cocultures containing amastigotes derived from infected mammalian cell monolayers.
DISCUSSION
This study shows that T. cruzi amastigotes present receptors for human fibronectin (Fig. 1) . In the presence of physiological concentrations of fibronectin, these receptors appear to increase the binding to and uptake of amastigotes by both murine macrophages and human monocytes. The enhancing effect of Fn on amastigote binding to and uptake by these two types of phagocytic cells appears to be specific since anti-human Fn F(ab')2 fragments can inhibit it (Tables  1 and 5) , apparently by interacting with the Fn molecule.
The fact that pretreatment of either macrophage or T. cruzi amastigotes with Fn intensifies the degree of parasite binding to and uptake by macrophages indicates that Fn receptors on both amastigotes (as stated previously) and macrophages (27) are responsible for the effect of Fn on amastigote-phagocyte cell interactions. This finding suggests that T. cruzi amastigote binding to and uptake by mononuclear phagocytic cells is mediated in part by the interaction of amastigote-bound Fn with macrophage and monocyte Fn The observation that inflammatory cells surrounding tissue lesions contain amastigotes (7) and the fact that macrophages, monocytes, eosinophils, and neutrophils take up and destroy these forms of the parasite released from mammalian cells (20) (21) (22) (23) (20) (21) (22) (23) (3) .
Our findings that T. cruzi amastigotes present receptors for Fn, together with the observations of others that trypomastigote (11, 26) and epimastigote (13) 
